AROC three-lens brief
Evidence-based stock research on AROC. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -4.41% yesterday. · 50-day MA below 200-day MA (death-cross regime); price below both.
- Moved -4.41% yesterday.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 11.6pp over 30 days.
- Analyst mean target $42.38 — 59% above current (8 analysts).
- Reported earnings on 2026-11-03.
AROC closed at $26.65 (-4.41%) as of 2026-11-12. Market cap: $4.67B. P/E (trailing) 13.7. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $42.38 — 59% above current (8 analysts).. Concerns: moved -4.41% yesterday.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $370.81M, net income $84.47M, free cash flow $216.74M.
Why three lenses on AROC, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AROC across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AROC" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AROC brief"></iframe>